newsfilter
← Latest News
ACCESS Newswire·

FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)

MVID has a lethal natural history requiring life-sustaining parenteral support , which includes total parenteral nutrition , which is associated with significant toxicities; PS reduction could potentially reduce